304 related articles for article (PubMed ID: 14520701)
1. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
Conzelmann M; Dieterle CP; Linnemann U; Berger MR
Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
[TBL] [Abstract][Full Text] [Related]
2. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?
Conzelmann M; Linnemann U; Berger MR
Int J Colorectal Dis; 2005 Mar; 20(2):137-46. PubMed ID: 15459772
[TBL] [Abstract][Full Text] [Related]
4. Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR.
Weber T; Lacroix J; Wörner S; Weckauf H; Winkler S; Hinz U; Schilling T; Frank-Raue K; Klar E; Knebel Doeberitz Mv Mv
Int J Cancer; 2003 Jan; 103(1):126-31. PubMed ID: 12455065
[TBL] [Abstract][Full Text] [Related]
5. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.
Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S
Int J Cancer; 2004 Jan; 108(3):412-7. PubMed ID: 14648708
[TBL] [Abstract][Full Text] [Related]
6. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
[TBL] [Abstract][Full Text] [Related]
7. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
8. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression.
Lassmann S; Bauer M; Rosenberg R; Nekarda H; Soong R; Rüger R; Höfler H; Werner M
Int J Colorectal Dis; 2004 Mar; 19(2):87-94. PubMed ID: 13680284
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of detecting lymph node micrometastasis of colorectal cancer by reverse transcriptase-polymerase chain reaction (RT-PCR)].
Yuan HY; Cheng FL; Wei ZZ; Yang GL; Chen JK
Ai Zheng; 2004 Sep; 23(9):1069-73. PubMed ID: 15363204
[TBL] [Abstract][Full Text] [Related]
10. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
[TBL] [Abstract][Full Text] [Related]
11. Detection of disseminated tumour cells in the liver of colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Eur J Surg Oncol; 2005 Feb; 31(1):38-44. PubMed ID: 15642424
[TBL] [Abstract][Full Text] [Related]
12. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
[TBL] [Abstract][Full Text] [Related]
14. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.
Vlems FA; Diepstra JH; Cornelissen IM; Ruers TJ; Ligtenberg MJ; Punt CJ; van Krieken JH; Wobbes T; van Muijen GN
Mol Pathol; 2002 Jun; 55(3):156-63. PubMed ID: 12032226
[TBL] [Abstract][Full Text] [Related]
15. Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients.
Wong CS; Cheung MT; Ma BB; Pun Hui E; Chan AC; Chan CK; Lee KC; Cheuk W; Lam MY; Wong MC; Chan CM; Chan JK; Chan AT
Int J Surg Pathol; 2008 Apr; 16(2):119-26. PubMed ID: 18387990
[TBL] [Abstract][Full Text] [Related]
16. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
[TBL] [Abstract][Full Text] [Related]
17. Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes.
Soong R; Beyser K; Basten O; Kalbe A; Rueschoff J; Tabiti K
Clin Cancer Res; 2001 Nov; 7(11):3423-9. PubMed ID: 11705858
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
Fava TA; Desnoyers R; Schulz S; Park J; Weinberg D; Mitchell E; Waldman SA
J Clin Oncol; 2001 Oct; 19(19):3951-9. PubMed ID: 11579116
[TBL] [Abstract][Full Text] [Related]
19. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
